These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15950208)
21. Antigen-specific therapies in multiple sclerosis. Sospedra M; Martin R Int Rev Immunol; 2005; 24(5-6):393-413. PubMed ID: 16318988 [TBL] [Abstract][Full Text] [Related]
22. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides. Fontoura P; Garren H; Steinman L Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989 [TBL] [Abstract][Full Text] [Related]
23. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828 [TBL] [Abstract][Full Text] [Related]
24. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958 [TBL] [Abstract][Full Text] [Related]
25. The role of T cell receptor dimerization for T cell antagonism and T cell specificity. Salzmann M; Bachmann MF Mol Immunol; 1998 Apr; 35(5):271-7. PubMed ID: 9747887 [TBL] [Abstract][Full Text] [Related]
26. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824 [TBL] [Abstract][Full Text] [Related]
27. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes. Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515 [TBL] [Abstract][Full Text] [Related]
28. Age-dependent TCR revision mediated by interaction between alphabeta TCR and self-antigens. Takase M; Kanagawa EM; Kanagawa O J Immunol; 2007 Aug; 179(4):2163-9. PubMed ID: 17675475 [TBL] [Abstract][Full Text] [Related]
29. Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex. Patarroyo ME; Salazar LM; Cifuentes G; Lozano JM; Delgado G; Rivera Z; Rosas J; Vargas LE Biochimie; 2006 Feb; 88(2):219-30. PubMed ID: 16126320 [TBL] [Abstract][Full Text] [Related]
30. Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide. Larkin J; Picca CC; Caton AJ Eur J Immunol; 2007 Jan; 37(1):139-46. PubMed ID: 17154263 [TBL] [Abstract][Full Text] [Related]
31. [Advances in the study of molecular mechanisms, applications and screening for altered peptide ligand]. Wang QQ; Yang HZ; Hu ZW Yao Xue Xue Bao; 2008 Feb; 43(2):113-7. PubMed ID: 18507334 [TBL] [Abstract][Full Text] [Related]
32. CD4+CD25+ regulatory T cells are activated in vivo by recognition of self. Andersson J; Stefanova I; Stephens GL; Shevach EM Int Immunol; 2007 Apr; 19(4):557-66. PubMed ID: 17369190 [TBL] [Abstract][Full Text] [Related]
33. Idiotypic T cells specific for Morbillivirus nucleocapsid protein process and present their TCR to cognate anti-idiotypic CD8+ T cells. Lal G; Shaila MS; Nayak R Immunol Lett; 2006 Feb; 102(2):132-40. PubMed ID: 16188324 [TBL] [Abstract][Full Text] [Related]
34. Altered peptide ligands induce delayed CD8-T cell receptor interaction--a role for CD8 in distinguishing antigen quality. Yachi PP; Ampudia J; Zal T; Gascoigne NR Immunity; 2006 Aug; 25(2):203-11. PubMed ID: 16872849 [TBL] [Abstract][Full Text] [Related]
35. T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells. Hudrisier D; Riond J; Garidou L; Duthoit C; Joly E Eur J Immunol; 2005 Aug; 35(8):2284-94. PubMed ID: 16021601 [TBL] [Abstract][Full Text] [Related]
36. Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Huseby ES; Crawford F; White J; Marrack P; Kappler JW Nat Immunol; 2006 Nov; 7(11):1191-9. PubMed ID: 17041605 [TBL] [Abstract][Full Text] [Related]
38. How a home-grown T cell receptor interacts with a foreign landscape. Rossjohn J; McCluskey J Cell; 2007 Apr; 129(1):19-20. PubMed ID: 17418777 [TBL] [Abstract][Full Text] [Related]
39. TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development. Erlacher M; Knoflach M; Stec IE; Böck G; Wick G; Wiegers GJ Eur J Immunol; 2005 Nov; 35(11):3287-96. PubMed ID: 16224812 [TBL] [Abstract][Full Text] [Related]
40. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]